Clinical trial
Antiproteinuric Agents and Fabry Disease
NCT00343577 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00343577 |
|---|---|
| Title | Antiproteinuric Agents and Fabry Disease |
| Official title | Observational Study of Antiproteinuric Agents in Patients With Fabry Disease Treated With Enzyme Replacement Therapy |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Fabry Disease, Proteinuria |
| Enrollment | 12 |
| Start date | Jan 1, 2001 |
| Completion | Dec 1, 2006 |
| First posted | Jun 23, 2006 |
| Last update posted | Nov 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: